The integration of AI into drug submission and approval processes signifies a shift towards more efficient pharmaceutical development. The potential benefits are substantial, including faster ...

The new director at the FDA overseeing medical devices will confront criticisms about hasty approvals as she ushers in ...

RFK Jr., a longtime anti-vaccine activist, to play a role in Trump administration and potentially influence how the FDA and ...

FELIQS plans to conduct a Phase 1b/2 study of FLQ-101 (tROPhy-1 study) both in the US and Japan in the first quarter of 2025.

Some health experts say Kennedy, even in an informal role, could potentially lead to real consequences for patients, ...

In the rainy season of 2020, the Forestry Development Authority (FDA) investigated the scale of abandoned logs in Grand Bassa ...

For market entry strategy for drugs in Japan, understanding the submission requirements is as crucial as the documentation itself. The submission dossier must be meticulously prepared, containing all ...

An analysis of SpringWorks Therapeutics, Inc., including recent FDA approval, promising sales, and future funding for ...

Multiple players are exploring whether modalities designed to combat B cell malignancies can be repurposed against lupus, ...

The US FDA has granted fast track designation to FELIQS’ lead product FLQ-101 for preventing retinopathy of prematurity (ROP) ...

Gene therapy has emerged as a transformative technology, offering life-changing treatments for conditions with few options.

The path from a scientist’s initial idea to a new medicine that can save lives is a complex and often lengthy process. It ...